Nutrition Supplement for Cystic Fibrosis

This trial aims to determine if a specific nutrition supplement is more effective for adults with cystic fibrosis, a condition affecting the lungs and digestive system. It compares a common supplement formula to one containing less common nutrient forms. Participants will take one of the supplements for six weeks, with blood tests conducted before and after to assess nutrient absorption and utilization. Individuals with cystic fibrosis who have pancreatic issues and are undergoing specific treatments might be suitable candidates for this trial. As an unphased trial, this study provides participants the opportunity to contribute to important research that could enhance nutritional care for cystic fibrosis patients.

The trial does not specify if you must stop all current medications, but you cannot participate if you are taking certain medications like azole antifungals or those that are sensitive CYP3A4 substrates. It's best to discuss your specific medications with the trial team.

Research has shown that nutritional supplements, including those with less common nutrient types, are generally safe for people with cystic fibrosis. One study found that these supplements can improve appetite, nutrition, and lung function in these individuals. Other research has also shown that blood levels of certain vitamins, such as E and Selenium, increased significantly with supplementation, indicating good absorption by the body.

Researchers are excited about these treatments for cystic fibrosis because they explore the potential benefits of using uncommon nutrient forms, which aren't typically found in standard supplements. Most conventional supplements rely on widely used nutrient forms, but this trial is testing if these less common forms can provide unique advantages in managing cystic fibrosis. By introducing these alternative nutrient options, the study aims to uncover new ways to improve the health and well-being of individuals with this condition.

Studies have shown that people with cystic fibrosis often struggle to absorb fats, which also impacts their intake of essential vitamins like A, D, and E. This trial will compare two supplementation approaches. Participants in one group will receive supplements with conventional nutrient forms, while another group will receive supplements with less common nutrient forms. Research suggests that these less common forms might enhance nutrient absorption in individuals with cystic fibrosis, potentially improving their nutrition. For instance, certain treatments have increased blood levels of vitamin E without additional supplements. This indicates that different nutrient forms, not typically found in regular supplements, may more effectively boost nutrient levels. Improved nutrient levels could lead to overall health benefits for people with cystic fibrosis.¹²³⁴⁵